- Home
- AQST vs FVCB Comparison
AQST vs FVCB Comparison
Compare AQST & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- FVCB
- Stock Information
- Founded
- AQST 2004
- FVCB 2007
- Country
- AQST United States
- FVCB United States
- Employees
- AQST N/A
- FVCB N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- FVCB Major Banks
- Sector
- AQST Health Care
- FVCB Finance
- Exchange
- AQST Nasdaq
- FVCB Nasdaq
- Market Cap
- AQST 254.1M
- FVCB 248.5M
- IPO Year
- AQST 2018
- FVCB N/A
- Fundamental
- Price
- AQST $2.79
- FVCB $11.60
- Analyst Decision
- AQST Strong Buy
- FVCB
- Analyst Count
- AQST 5
- FVCB 0
- Target Price
- AQST $11.40
- FVCB N/A
- AVG Volume (30 Days)
- AQST 939.1K
- FVCB 67.6K
- Earning Date
- AQST 05-12-2025
- FVCB 04-22-2025
- Dividend Yield
- AQST N/A
- FVCB N/A
- EPS Growth
- AQST N/A
- FVCB 311.46
- EPS
- AQST N/A
- FVCB 1.03
- Revenue
- AQST $57,561,000.00
- FVCB $60,453,000.00
- Revenue This Year
- AQST N/A
- FVCB $8.48
- Revenue Next Year
- AQST $39.51
- FVCB $7.88
- P/E Ratio
- AQST N/A
- FVCB $11.44
- Revenue Growth
- AQST 13.79
- FVCB 34.53
- 52 Week Low
- AQST $2.20
- FVCB $9.49
- 52 Week High
- AQST $5.80
- FVCB $14.50
- Technical
- Relative Strength Index (RSI)
- AQST 49.93
- FVCB 61.72
- Support Level
- AQST $2.59
- FVCB $11.40
- Resistance Level
- AQST $3.05
- FVCB $12.21
- Average True Range (ATR)
- AQST 0.16
- FVCB 0.41
- MACD
- AQST 0.00
- FVCB 0.09
- Stochastic Oscillator
- AQST 43.57
- FVCB 73.07
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About FVCB FVCBankcorp Inc.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.